Back to Search
MICHAEL SZAREK, D.M.D., M.S.
D.M.D., M.S.
General Practice Dentistry
NPI: 1396728556Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
18766(MA)
Research & Publications (20)
Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
PMID 19147732·Clin Chem·2009
4-observational
Nonparametric estimation in a Markov "illness-death" process from interval censored observations with missing intermediate transition status.
PMID 18505421·Biometrics·2009
8-other
Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
PMID 19497447·J Am Coll Cardiol·2009
2-rct
Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study.
PMID 19322096·Eur J Cardiovasc Prev Rehabil·2009
4-observational
Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).
PMID 18972097·Diabetologia·2009
4-observational
Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).
PMID 19231315·Am J Cardiol·2009
4-observational
Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study.
PMID 17991875·Arterioscler Thromb Vasc Biol·2008
2-rct
The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).
PMID 18777490·Diab Vasc Dis Res·2008
4-observational
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.
PMID 18519851·Circulation·2008
8-other
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.
PMID 18077795·Neurology·2008
2-rct
Effects of high-dose atorvastatin in patients > or =65 years of age with acute coronary syndrome (from the myocardial ischemia reduction with aggressive cholesterol lowering [MIRACL] study).
PMID 17317362·Am J Cardiol·2007
2-rct
Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
PMID 17962589·Stroke·2007
2-rct
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.
PMID 17898099·N Engl J Med·2007
4-observational
Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS).
PMID 17894827·Diabet Med·2007
2-rct
High-dose atorvastatin after stroke or transient ischemic attack.
PMID 16899775·N Engl J Med·2006
4-observational
Cytoplasmic melanoma-associated antigen (CYT-MAA) serum level in patients with melanoma: a potential marker of response to immunotherapy?
PMID 16450373·Int J Cancer·2006
2-rct
Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients.
PMID 16377285·Am J Cardiol·2006
1-meta
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.
PMID 16287954·JAMA·2005
4-observational
Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: an analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial.
PMID 16186288·Diabetes Care·2005
4-observational
Presence and prognostic significance of melanoma-associated antigens CYT-MAA and HMW-MAA in serum of patients with melanoma.
PMID 16117794·J Invest Dermatol·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 75 ARCAND DR, PROFESSIONAL PARK
LOWELL, MA 01852 - Phone
- (978) 454-9332
Quick Facts
- NPI
- 1396728556
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile